You are here

oncology

Injection That Makes Colorectal Cancer ‘Glow’ During Surgery Enters Phase 3 Trial

Forbes

Wed, 10/30/19 - 10:58 pm

colorectal cancer

As Amgen zeroes in on cancer, neuroscience pipeline under the ax

Fierce Biotech

Wed, 10/30/19 - 10:20 am

With Ex-Medivation Exec Hung at Helm, Nuvation Nabs $275M for Cancer

Xconomy

Mon, 10/28/19 - 10:49 am

Glenmark spin-out aims to challenge Amgen, others in cancer bispecific field

Biopharma Dive

Tue, 10/15/19 - 10:21 pm

Ichnos Sciences

bispecific antibodies

Qiagen and Illumina in It for the Long Haul with 15-year Collaboration

Medical Devices and Diagnostics Industry

Tue, 10/8/19 - 09:04 pm

FDA leaders worry agency will lose out on talent in gene therapy, cancer fields

Biopharma Dive

Tue, 10/8/19 - 09:54 am

‘There are moments’: Sanofi’s new CEO is thinking through the R&D strategy — and oncology will be key

Endpoints

Tue, 10/1/19 - 09:55 am

Shiny, new and expensive: ESMO studies find new cancer drugs carry higher prices, add little benefit

Fierce Pharma

Fri, 09/27/19 - 10:46 am

Oncologists listen when the FDA speaks, even after a drug hits the market

Endpoints

Thu, 09/26/19 - 10:47 am

Pfizer expands real-world data collaboration with Flatiron Health

Pharmaceutical Business Review

Thu, 09/26/19 - 10:42 am

Flatiron Health

real world data

GSK invests $120M in biopharma plant as renewed oncology bets grow

Fierce Pharma

Wed, 09/25/19 - 11:37 pm

drug manufacturing

Overcoming Cancer Drug Resistance with A Bispecific Inhibitor

Xtalks

Wed, 09/25/19 - 10:21 am

drug resistance

bispecific antibodies

Cancer centers stretching to keep up with pharma's oncology interest

Biopharma Dive

Mon, 09/23/19 - 07:47 pm

immuno-oncology

clinical trials

Mike Quigley has personal motivation leading oncology at Bristol-Myers Squibb

Bizjournals

Sat, 09/21/19 - 12:35 pm

Bristol-Myers Squibb

cancer immunotherapy

Evidence underpinning approval of new cancer drugs raises questions

Medical Express

Wed, 09/18/19 - 07:08 pm

Pfizer hires ex-FDA, MD Anderson researcher as clinical oncology lead

Fierce Biotech

Thu, 09/12/19 - 11:56 am

Benevolent AI and Novartis sign AI R&D deal

Pharmaforum

Fri, 09/6/19 - 10:14 am

artificial intelligence

The promise and pitfalls of molecular testing in oncology

Pharmaforum

Sat, 08/31/19 - 07:44 pm

emerging markets

molecular testing

Sanofi defends top oncology drug with Jevtana patent win

Fierce Pharma

Thu, 08/15/19 - 12:21 pm

AstraZeneca cancer drugs build as primary care shrinks

Biopharma Dive

Mon, 08/12/19 - 12:08 pm

Pages